Spark Investment Management LLC - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 11 filers reported holding SINOVAC BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$029,1000.0%0.00%
Q2 2023$029,1000.0%0.00%
Q3 2022$029,1000.0%0.00%
Q2 2022$029,1000.0%0.00%
Q4 2021$029,1000.0%0.00%
Q3 2021$029,1000.0%0.00%
Q2 2021$029,1000.0%0.00%
Q1 2021$029,1000.0%0.00%
Q4 2020$029,1000.0%0.00%
Q3 2020$029,1000.0%0.00%
Q2 2020$029,1000.0%0.00%
Q1 2020$029,1000.0%0.00%
Q4 2019$029,1000.0%0.00%
Q3 2019$029,1000.0%0.00%
Q2 2019$029,1000.0%0.00%
Q1 2019$0
-100.0%
29,1000.0%0.00%
-100.0%
Q4 2018$201,000
-33.2%
29,100
-26.5%
0.01%
-17.6%
Q3 2018$301,000
+2.0%
39,6000.0%0.02%0.0%
Q2 2018$295,000
-48.2%
39,600
-40.1%
0.02%
-52.8%
Q1 2018$569,000
+9.4%
66,1000.0%0.04%
+28.6%
Q4 2017$520,000
+316.0%
66,100
+271.3%
0.03%
+300.0%
Q3 2017$125,000
-57.2%
17,800
-58.9%
0.01%
-61.1%
Q2 2017$292,000
-6.4%
43,300
-20.7%
0.02%
-10.0%
Q1 2017$312,000
+57.6%
54,600
+62.5%
0.02%
+25.0%
Q4 2016$198,000
+224.6%
33,600
+226.2%
0.02%
+166.7%
Q2 2016$61,000
-1.6%
10,300
-6.4%
0.01%
-25.0%
Q4 2015$62,000
-55.1%
11,000
-52.6%
0.01%
-75.0%
Q3 2013$138,000
+213.6%
23,200
+105.3%
0.03%
+166.7%
Q2 2013$44,00011,3000.01%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 35,884$188,0000.17%
Orbimed Advisors 2,667,500$14,004,0000.10%
Freedom Investment Management, Inc. 157,295$826,0000.08%
Pine River Capital Management L.P. 1,095,041$5,749,0000.06%
FIRST MANHATTAN CO. LLC. 603,666$3,169,0000.02%
FIL Ltd 1,091,500$5,730,0000.02%
Renaissance Technologies 1,263,200$6,632,0000.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 179,899$944,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 4,068,406$21,359,0000.01%
ProShare Advisors LLC 44,592$234,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders